Canaccord Genuity Maintains Buy on GeneDx Holdings, Raises Price Target to $170

Benzinga · 3d ago
Canaccord Genuity analyst Kyle Mikson maintains GeneDx Holdings (NASDAQ:WGS) with a Buy and raises the price target from $160 to $170.